Navigation Links
Human Membranes Crystal Structure may Help Tailor Asthma Drugs

Scientists have managed to reveal the crystal structure of a human membrane protein, LTC4 synthase, which has a major influence on the development of asthma .

LTC4 synthase is tremendously difficult to analyse, and previously only low-resolution information has been available on two membrane protein structures from human.

Now, researchers at Karolinska Institutet in Sweden believe that their work will facilitate the development of new and better therapeutics against inflammations in the pulmonary tract.

Asthma attacks are caused by a severe inflammatory reaction in the airways, a reaction that is largely due to actions of LTC4 synthase. For this reason asthma medicines often aim at blocking the downstream effects of LTC4 synthase.

However, there is a need for new pharmaceutical alternatives, as not all patients respond to the existing medicines.

Now, scientists at the Department of Medical Biochemistry and Biophysics have, with the help of the two EU networks Eicosanox and E-Mep, elucidated the three dimensional structure of the LTC4 synthase at 2.0 resolution.

It is clear from the structure that the protein has three identical subunits, each of them consisting of four spiral structures that cover the nuclear membrane.

Also the exact position and characteristics of the active sites, where activating or blocking molecules can attach, have been identified. With this knowledge it is now achievable to shape new molecules that can block the LTC4 synthase.

The new results are also very important as they can lead the way for the development of new and more effective therapeutics against other diseases.

Some 40 percent of the proteins of interest for pharmaceutical developments are membrane proteins. The current study is likely to lead the way for the determination of structures of other human m embrane proteins.


'"/>




Related medicine news :

1. Human Genome Project Achieves Technological Triumph
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Human gene number increases
4. Scientists found ancient Human Germ Killer
5. New standards for Human Research Safety
6. Human wasting disease linked to a gene
7. The Human Mad Cow Case
8. Human Growth Hormone Found To be Dangerous For Human Use
9. Human Antibody That Can Block SARS
10. Human immunity system can battle HIV.
11. Two New Human Papilloma virus (HPV) vaccines to prevent cervical cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent ... health departments have been awarded five-year accreditation status through the Public Health ... being served by a PHAB-accredited health department now extend to more than ...
(Date:9/21/2017)... ... September 21, 2017 , ... Preora Diagnostics Inc. ... screening tests, has received two prestigious recognitions that acknowledge the promise of its ... Preora has been named a Top 100 Finalist for the 16th annual ...
(Date:9/21/2017)... Fort Payne, AL (PRWEB) , ... September 21, ... ... financial preparation provider with offices serving communities in northern Alabama and Georgia, is ... positive breast cancer prevention by utilizing modern early detection methods. , US ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... of the Best Places to Work in the Research Triangle for 2017. , ... nominated, a company had to meet a threshold in employee participation--a percentage that ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... exhibitors at the East-coast edition of MarTech: The Marketing Tech Conference October 2–4, ... together more than 40 speakers — representing such thought-leading companies as JP ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... ORANGEBURG, N.Y. , Sept. 6, 2017   PDI ... today announced it will host an educational session focused ... line-associated bloodstream infection (CLABSI) prevention at the 2017 Annual ... meeting, which will take place at the ... Arizona from Sept. 16-19, will also feature ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... -- Xyntek Inc. has announced another milestone in their continued growth and success of ... growing demands of customer engagements regionally.  ... Midwest office is located at 318 West Adams Street, Suite 1528, Chicago, IL ... Xyntek's recently opened Midwest ... In ...
Breaking Medicine Technology: